Optics
← Today's headlines

5 sources checked · source map still forming · 1h ago

Needs Review

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

0 Left5 Center0 Right
Needs review. This source map is too narrow, too early, or mixed-format to trust yet.

NEEDS REVIEW

As of September 9, 2026 at 10:00 AM, this is how Optics News reads the wording differences in this story.

What happened A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.
The headline split The headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidence Developing. Only 5 sources are matched, and the source map is still narrow. Useful to watch, not enough to draw conclusions yet.
Same-event confidenceDeveloping

Not enough sources yet to confirm this is the same specific event.

Wording differs, but the match is too narrow to read confidently yet.

WHAT EACH SIDE EMPHASIZED

Left / center-leftNo matching source in this bucket yet.

Optics keeps watching for pickup.

CenterDoctors stunned after promising heart drug fails major study

The Plain Dealer (Cleveland.com) · Center · News report

Right / center-rightNo matching source in this bucket yet.

Optics keeps watching for pickup.

SEE THE HEADLINES

CenterHigh
The Plain Dealer (Cleveland.com)News report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
CenterHigh
The Star-Ledger (NJ.com)News report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
CenterMostly Factual
OregonianNews report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
CenterHigh
The Birmingham News (AL.com)News report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
CenterHigh
The Grand Rapids Press (MLive)News report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
DetailsScore hidden · 5 sources · 1 bias buckets
Score hidden until the match is cleanerLow confidence5 sources · 1 bias bucketsDeveloping · 5 sources · 1 bucketFormats: News report

SOURCE MAP CHANGES

Sep 9, 10:00 AM: The Plain Dealer (Cleveland.com) joined the source map.

Sep 9, 10:00 AM: The Star-Ledger (NJ.com) joined the source map.

Sep 9, 10:00 AM: Oregonian joined the source map.

Sep 9, 10:00 AM: The Birmingham News (AL.com) joined the source map.

Now: score hidden until the source match is cleaner. Story health is developing · 5 sources · 1 bucket.